Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial.
Saved in:
| Title: | Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial. |
|---|---|
| Authors: | Diya, Oyeniyi1 (AUTHOR), Gayed, Juleen1 (AUTHOR) juleen.gayed@pfizer.com, Lowry, Francine S.2 (AUTHOR), Ma, Hua2 (AUTHOR), Bangad, Vishva2 (AUTHOR), Mensa, Federico3 (AUTHOR), Zou, Jing4 (AUTHOR), Xie, Xuping4 (AUTHOR), Hu, Yanping4 (AUTHOR), Cutler, Mark5 (AUTHOR), Belanger, Todd5 (AUTHOR), Cooper, David5 (AUTHOR), Xu, Xia2 (AUTHOR), Mogg, Robin2 (AUTHOR), Türeci, Özlem3 (AUTHOR), Şahin, Uǧur3 (AUTHOR), Swanson, Kena A.5 (AUTHOR), Modjarrad, Kayvon5 (AUTHOR), Anderson, Annaliesa S.5 (AUTHOR), Gurtman, Alejandra5 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Aug2025, Vol. 14 Issue 8, p1973-1987. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 187262111 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Diya%2C+Oyeniyi%22">Diya, Oyeniyi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gayed%2C+Juleen%22">Gayed, Juleen</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> juleen.gayed@pfizer.com</i><br /><searchLink fieldCode="AR" term="%22Lowry%2C+Francine+S%2E%22">Lowry, Francine S.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ma%2C+Hua%22">Ma, Hua</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bangad%2C+Vishva%22">Bangad, Vishva</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mensa%2C+Federico%22">Mensa, Federico</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zou%2C+Jing%22">Zou, Jing</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xie%2C+Xuping%22">Xie, Xuping</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hu%2C+Yanping%22">Hu, Yanping</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cutler%2C+Mark%22">Cutler, Mark</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Belanger%2C+Todd%22">Belanger, Todd</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cooper%2C+David%22">Cooper, David</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xu%2C+Xia%22">Xu, Xia</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mogg%2C+Robin%22">Mogg, Robin</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Türeci%2C+Özlem%22">Türeci, Özlem</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Şahin%2C+Uǧur%22">Şahin, Uǧur</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Swanson%2C+Kena+A%2E%22">Swanson, Kena A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Modjarrad%2C+Kayvon%22">Modjarrad, Kayvon</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Anderson%2C+Annaliesa+S%2E%22">Anderson, Annaliesa S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gurtman%2C+Alejandra%22">Gurtman, Alejandra</searchLink><relatesTo>5</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Infectious+Diseases+%26+Therapy%22">Infectious Diseases & Therapy</searchLink>. Aug2025, Vol. 14 Issue 8, p1973-1987. 15p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=187262111 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40121-025-01185-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 15 StartPage: 1973 Titles: – TitleFull: Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diya, Oyeniyi – PersonEntity: Name: NameFull: Gayed, Juleen – PersonEntity: Name: NameFull: Lowry, Francine S. – PersonEntity: Name: NameFull: Ma, Hua – PersonEntity: Name: NameFull: Bangad, Vishva – PersonEntity: Name: NameFull: Mensa, Federico – PersonEntity: Name: NameFull: Zou, Jing – PersonEntity: Name: NameFull: Xie, Xuping – PersonEntity: Name: NameFull: Hu, Yanping – PersonEntity: Name: NameFull: Cutler, Mark – PersonEntity: Name: NameFull: Belanger, Todd – PersonEntity: Name: NameFull: Cooper, David – PersonEntity: Name: NameFull: Xu, Xia – PersonEntity: Name: NameFull: Mogg, Robin – PersonEntity: Name: NameFull: Türeci, Özlem – PersonEntity: Name: NameFull: Şahin, Uǧur – PersonEntity: Name: NameFull: Swanson, Kena A. – PersonEntity: Name: NameFull: Modjarrad, Kayvon – PersonEntity: Name: NameFull: Anderson, Annaliesa S. – PersonEntity: Name: NameFull: Gurtman, Alejandra IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: Aug2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 21938229 Numbering: – Type: volume Value: 14 – Type: issue Value: 8 Titles: – TitleFull: Infectious Diseases & Therapy Type: main |
| ResultId | 1 |